32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

This study was conducted in March 2007 to assess acceptability of PIHCT and the factors influencing its uptake among TB patients in Addis Ababa. Institution-based, cross-sectional study was conducted and 423 TB patients interviewed. Most of the patients were initiated for HIV testing by their TB treatment supervisor 402(98.5%). Among those who were initiated by their treatment supervisor for HIV testing, 266(66.2%; 95%CI= 61.6-70.8) had under gone HIV testing. Adjusted correlates of acceptability of PIHCT include younger age group (20-24) (AOR=3.0, 95% CI=1.2-8.1), primary education (AOR=2.0,…mehr

Produktbeschreibung
This study was conducted in March 2007 to assess acceptability of PIHCT and the factors influencing its uptake among TB patients in Addis Ababa. Institution-based, cross-sectional study was conducted and 423 TB patients interviewed. Most of the patients were initiated for HIV testing by their TB treatment supervisor 402(98.5%). Among those who were initiated by their treatment supervisor for HIV testing, 266(66.2%; 95%CI= 61.6-70.8) had under gone HIV testing. Adjusted correlates of acceptability of PIHCT include younger age group (20-24) (AOR=3.0, 95% CI=1.2-8.1), primary education (AOR=2.0, 95% CI=1.04-3.8), secondary and above education (AOR=1.9, 95% CI=1.01-3.7), and recognition that any one should get tested for HIV (AOR=5.5, 95% CI=1.4-21.7). The reported barriers for acceptability of PIHCT include no risk perception for HIV infection 54(40.3%), tested before 53(39.3%), and fear of learning positive result 40 (29.8%) of the study participants. The wide spread support, and evidence of high acceptability of PIHCT in this study holds significant promise for the control, prevention and treatment of both HIV/AIDS and TB
Autorenporträt
Ibrahim Nursien, MPH; Faculty of Medicine, Addis Ababa University, Ethiopia with more than five years experience working as lecturer in Debre Birhan University and public health practitioner with MOH, and international NGOs in development setting. Currently, he is working for Abt Associates Inc. as a TB/HIV program officer in Ethiopia.